Simplex Trading, LLC Nautilus Biotechnology, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$2.22 - $3.0 $372 - $504	-168 Reduced 77.78%	48 $0
Q1 2024 Apr 25, 2024	SELL	$2.41 - $3.18 $1,494 - $1,971	-620 Reduced 74.16%	216 $0
Q4 2023 Feb 02, 2024	BUY	$2.34 - $3.39 $1,956 - $2,834	836 New	836 $2,000
Q1 2023 Apr 27, 2023	BUY	$1.67 - $2.77 $98,446 - $163,291	58,950 Added 2725.38%	61,113 $169,000
Q4 2022 Feb 02, 2023	SELL	$1.55 - $2.47 $2,022 - $3,223	-1,305 Reduced 37.63%	2,163 $3,000
Q3 2022 Nov 04, 2022	BUY	$1.96 - $3.13 $6,797 - $10,854	3,468 New	3,468 $7,000
Q2 2022 Aug 03, 2022	SELL	$2.64 - $4.84 $49,869 - $91,427	-18,890 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.5 - $5.3 $216,443 - $327,757	-61,841 Reduced 76.6%	18,890 $81,000
Q4 2021 Feb 23, 2022	BUY	$4.45 - $6.21 $348,394 - $486,187	78,291 Added 3208.65%	80,731 $418,000
Q3 2021 Oct 28, 2021	BUY	$6.14 - $10.1 $1,842 - $3,030	300 Added 14.02%	2,440 $24,000
Q2 2021 Aug 12, 2021	BUY	$9.04 - $14.19 $19,345 - $30,366	2,140 New	2,140 $21,000

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $297M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.